Evoce Capital

Activity from announced rounds

All recorded activity

Evoce Capital is the investment firm named in Surf Therapeutics and Senticell financing histories.

Recorded funding activity

Surf develops non-invasive ultrasound neuromodulation for immune-mediated diseases. Senticell develops a liquid-biopsy diagnostic using nucleic acids associated with red blood cells. The companies pursue different therapeutic and diagnostic approaches rather than the same product.

Sources
Rounds participated in
3
Confirmed lead rounds
0
1 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$15M
3 disclosed · full round size, not this investor’s share

By stage

Seed2
Pre-seed1

By primary sector

Biotech2
Healthtech1

By country

United States3

Rounds

3 in all activity
Senticell

Senticell is developing a liquid-biopsy diagnostic based on nucleic acids associated with red blood cells.

$7MSeed
Participant
Surf Therapeutics

Develops non-invasive ultrasound neuromodulation therapies to treat immune-mediated diseases

$6MSeed
Role not disclosed
Intero Biosystems

Human intestinal organoids for preclinical research and testing.

$2MPre-seed
Participant